Today: 19 June 2026
Goldman Sachs stock rises more than 2% today as traders eye jobs data and bank earnings
2 January 2026
1 min read

Goldman Sachs stock rises more than 2% today as traders eye jobs data and bank earnings

NEW YORK, January 2, 2026, 11:38 ET — Regular session

  • Goldman Sachs shares rose about 2% in late morning trade as 2026 trading got underway.
  • Investors are shifting focus to next week’s U.S. jobs report and the start of big-bank earnings.
  • Goldman has flagged an earnings-release filing around mid-January in recent SEC paperwork.

Goldman Sachs (GS) shares rose 2.1% to $897.16 in late morning trading on Friday, after moving between $880.82 and $897.16.

The gains came as Wall Street opened 2026 on firmer footing, with technology stocks rebounding after late-December losses and investors tracking fresh tariff headlines from President Donald Trump’s administration.

The early move matters because a busy January calendar is about to test risk appetite and interest-rate expectations that have underpinned equities. “The market is looking for direction,” said Matthew Maley, chief market strategist at Miller Tabak, in a note focused on the week ahead. Reuters

For Goldman and other big U.S. banks, the near-term spotlight is shifting to macro data and earnings that can reshape expectations for trading activity, deal fees and client appetite for risk.

A key first marker is the U.S. employment report due Jan. 9, with inflation data close behind and fourth-quarter earnings season gathering pace in the weeks that follow.

Goldman, in a prospectus supplement filed on Dec. 31, said it intends to file its quarterly earnings release for the quarter and year ended Dec. 31 on a Form 8-K — a filing used to report material events — on or about Jan. 15.

Investors will be listening for commentary on mergers and acquisitions (M&A), underwriting and trading, areas where Goldman’s revenue can swing with market volatility and corporate confidence.

They will also watch for signs that client activity held up into year-end and whether management points to improving visibility for 2026 as liquidity returns after the holiday lull.

Trading was thin at the end of 2025, when U.S. markets closed for New Year’s Day and volumes ran light in the holiday-shortened week.

The stock’s next move is likely to hinge on whether incoming data keep rate-cut expectations steady and whether bank results show a pickup in dealmaking and market activity as the year begins.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Investors Eye MSGS and MSGE Stocks After Knicks Win NBA Championship
    June 18, 2026, 9:11 PM EDT. The New York Knicks' first NBA championship in 53 years has sparked investor interest in Madison Square Garden Sports (MSGS) and Madison Square Garden Entertainment (MSGE). MSGS owns the Knicks and benefits directly from the title through increased franchise value, fan engagement, merchandise sales, and sponsorship appeal. The Knicks rank as the sixth most valuable sports franchise globally, valued at $9.75 billion. Conversely, MSGE owns iconic venues like Madison Square Garden but not the Knicks themselves. MSGE could see indirect gains from heightened venue prestige and increased event demand. Investors should note the companies' distinct asset bases before investing to capitalize on the championship's financial impacts.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Intel stock jumps 6% today as CES chip launch nears — what traders are watching next
Previous Story

Intel stock jumps 6% today as CES chip launch nears — what traders are watching next

Cisco stock slips as CSCO turns ex-dividend; what investors are watching next
Next Story

Cisco stock slips as CSCO turns ex-dividend; what investors are watching next

Go toTop